A Study of Lemborexant in Chinese Participants With Insomnia Disorder

Summary

The primary purpose of this study is to confirm using polysomnography (PSG) that lemborexant 10 milligram (mg) is superior to placebo on objective sleep onset as assessed by latency to persistent sleep (LPS) during the last 2 nights of 1 month of treatment in participants with insomnia disorder.

Timeline

Start

2020-11-06

Primary completion

2023-03-17

Completion

2023-03-17

Publications

• Mi WF, Wen D, Xu L, Pan J, Gu P, Wang C, Tang J, Zhang L, Liu CF, Yuan C, Wang H, Yamakawa N, Takase T, Moline M, Lu L. A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder. Sleep Med. 2026 Mar;139:108722. doi: 10.1016/j.sleep.2025.108722. Epub 2025 Dec 18.

Drugs

Indications